Cc Biotech Ltd.

DataGardener
live
Micro

Cc Biotech Ltd.

11541952•Private Limited With Share Capital

The Cambridge Partnership, Dorot, Babraham Research Campus, Cambridge, CB223FH

Get Full Access

Visit WebsiteBook a Direct Call
Incorporated

29/08/2018

Company Age

7 years

Directors

3

Employees

4

SIC Code

72110

Risk

moderate risk

Company Overview

Registration, classification & business activity

Cc Biotech Ltd. (11541952) is a private limited with share capital incorporated on 29/08/2018 (7 years old) and registered in cambridge, CB223FH. The company operates under SIC code 72110 - research and experimental development on biotechnology.

Private Limited With Share Capital
SIC: 72110
Micro
Incorporated 29/08/2018
CB223FH
4 employees

Financial Overview

Total Assets

£110.6K

Liabilities

£532.1K

Net Assets

£-421.5K

Est. Turnover

£2.47M

AI Estimated
Unreported
Cash

£6.1K

Key Metrics

4

Employees

3

Directors

2

Shareholders

1

Patents

Board of Directors

2
M
matthew james cummings
director
D
david corcoran
director

Filed Documents

36
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:26-01-2026
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:28-08-2025
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:08-07-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:29-08-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:16-08-2024
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:28-06-2024
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:28-06-2024
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:28-06-2024
Memorandum Articles
Category:Incorporation
Date:05-04-2024
Resolution
Category:Resolution
Date:27-03-2024
Capital Allotment Shares
Category:Capital
Date:21-03-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:12-10-2023
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:04-09-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:28-07-2023
Change Account Reference Date Company Current Shortened
Category:Accounts
Date:12-06-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:15-05-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:05-09-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:05-05-2022
Second Filing Capital Allotment Shares
Category:Capital
Date:23-11-2021
Capital Allotment Shares
Category:Capital
Date:15-11-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:08-09-2021
Capital Allotment Shares
Category:Capital
Date:10-08-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:10-08-2021
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:25-02-2021
Second Filing Capital Allotment Shares
Category:Capital
Date:24-02-2021
Appoint Person Secretary Company With Name Date
Category:Officers
Date:23-02-2021
Capital Allotment Shares
Category:Capital
Date:23-02-2021
Capital Allotment Shares
Category:Capital
Date:19-02-2021
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:01-09-2020
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:05-08-2020
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:18-02-2020
Resolution
Category:Resolution
Date:10-02-2020
Capital Allotment Shares
Category:Capital
Date:27-09-2019
Change Person Director Company With Change Date
Category:Officers
Date:23-09-2019
Confirmation Statement With Updates
Category:Confirmation Statement
Date:19-09-2019
Incorporation Company
Category:Incorporation
Date:29-08-2018

Innovate Grants

4

This company received a grant of £122378.2 for Development Of Clinically Translatable Therapies For The Treatment And Prevention Of Bacterial Vaginosis. The project started on 01/02/2020 and ended on 31/10/2021.

This company received a grant of £340973.0 for Treatment Of Recurrent Bacterial Vaginosis Using Engineered Probiotic Bacteria. The project started on 01/01/2023 and ended on 31/03/2025.

+2 more grants available

Import / Export

Imports
12 Months0
60 Months1
Exports
12 Months0
60 Months0

Risk Assessment

moderate risk

International Score

Future Factor

fair

Performance Rating

Accounts

Typetotal exemption full
Due Date31/03/2027
Filing Date26/01/2026
Latest Accounts30/06/2025

Trading Addresses

C/O The Cambridge Partnership Limit, Babraham Hall, Babraham, Cambridge, Cambridgeshire, CB223AT
The Cambridge Partnership, Dorot, Babraham Research Campus, Cambridge, Cb22 3Fh, CB223FHRegistered

Contact

The Cambridge Partnership, Dorot, Babraham Research Campus, Cambridge, CB223FH